Christopher Moody

Department of Chemistry
University of Exeter

Research Goals
To develop new chemotherapeutic agents using the concept of bioreductive activation, not only for hypoxia selective drugs, but also to deliver agents (e.g. inhibitors of key enzymes, anti-angiogenic agents) which target processes important for tumour growth.